About Acala Tech 100mg - Acalabrutinib Tablets
Background and Date of approval ACALABRUTINIB
Acalabrutinib is an anticancer medicine containing the active constituent acalabrutinib. It belongs to a class of drugs called Bruton's tyrosine kinase (BTK) inhibitors. Acalabrutinib was first approved by the U.S. Food and Drug Administration (FDA) on October 31, 2017, to treat adult patients with mantle cell lymphoma who have received at least one prior therapy. It was later approved by the FDA on August 17, 2020, for the treatment of adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Uses of ACALABRUTINIB
Acalabrutinib is used to treat mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL). MCL, CLL, and SLL are cancers of the white blood cells called lymphocytes that are part of the immune system.
How is ACALABRUTINIB administered?
Acalabrutinib is typically administered through injection by a healthcare provider. The specific method of administration may vary depending on the condition being treated and the healthcare provider's instructions. If a dose is missed, the patient should contact their healthcare provider for further instructions.
Side Effects of ACALABRUTINIB
Common side effects may include headache, diarrhea, fatigue, and muscle aches. Serious side effects may include bleeding, infections, heart rhythm problems, and lung inflammation. Acalabrutinib may also increase the risk of developing other types of cancer.
Advanced Oncology TherapyAcala Tech 100mg offers an advanced solution for cancer patients, utilizing Acalabrutinib as its active ingredient. Provided in film-coated tablets, this product ensures efficient delivery and optimal absorption when taken orally. Designed for use only by prescription, it upholds rigorous pharmaceutical standards and is indicated for patients as directed by their oncologist.
Reliable Pharmaceutical PackagingEvery pack of Acala Tech 100mg contains 30 tablets securely packed in an HDPE bottle with an outer box to ensure stability and protection. The robust packaging helps maintain the integrity of the medication, shielding it from light and moisture, and supports safe storage at temperatures below 30C.
FAQ's of Acala Tech 100mg - Acalabrutinib Tablets:
Q: How should Acala Tech 100mg tablets be taken?
A: Acala Tech 100mg tablets should be swallowed whole with water, following the exact dosage and schedule prescribed by your oncologist. Do not crush, chew, or split the tablets.
Q: What is the primary benefit of using Acalabrutinib in Acala Tech 100mg?
A: Acalabrutinib targets specific pathways in cancer cells, helping to inhibit their growth and spread, making it an effective therapy for certain oncology patients as determined by your oncologist.
Q: When will I notice the effects of Acala Tech 100mg?
A: The timeline for noticing effects can vary by individual and cancer type. Your oncologist will monitor your response throughout the treatment and make any necessary adjustments.
Q: Where should I store Acala Tech 100mg tablets?
A: Store the tablets below 30C in their original HDPE bottle and box. Protect the medication from light and moisture, and always keep it out of reach of children.
Q: What precautions should I take while using this medication?
A: Use Acala Tech 100mg only as prescribed by an oncologist. Regularly attend follow-up appointments and notify your doctor of any side effects or medication interactions.
Q: Is Acala Tech 100mg available without a prescription?
A: No, Acala Tech 100mg is a prescription-only medication and must be dispensed and used strictly under the supervision of a qualified oncologist.